TVTX - Travere Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$76.00
DETAILS
HIGH:
$89.00
LOW:
$67.00
MEDIAN:
$74.00
CONSENSUS:
$76.00
UPSIDE:
44.54%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Cooperman | 1,440,469 | $81.8M | 0.0% | +603,925 | INCREASED |
| Wood | 478,860 | $27.2M | 0.0% | +478,860 | INCREASED |
| Greenblatt | 27,628 | $1.6M | 0.0% | -749 | DECREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-15 | Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 43,735 | $26.88 | $1.2M |
| 2026-10-15 | Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 78,400 | $55.02 | $4.3M |
| 2026-10-15 | Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 128,065 | $52.97 | $6.8M |
| 2026-10-15 | Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | SELL | 37,270 | $54.20 | $2.0M |
| 2026-10-15 | Dube Eric M | director, officer: CHIEF EXECUTIVE OFFICER | M-Exempt | 200,000 | $8.93 | $1.8M |
| 2026-09-15 | REED ELIZABETH E | officer: Chief Legal Officer and GC | SELL | 21,926 | $62.03 | $1.4M |
| 2026-09-17 | Heerma Peter | officer: EVP, CHIEF COMMERCIAL OFFICER | M-Exempt | 8,282 | $22.40 | $186K |
| 2026-09-15 | Heerma Peter | officer: EVP, CHIEF COMMERCIAL OFFICER | M-Exempt | 39,283 | $26.88 | $1.1M |
| 2026-09-15 | Heerma Peter | officer: EVP, CHIEF COMMERCIAL OFFICER | SELL | 27,421 | $62.59 | $1.7M |
| 2026-09-15 | Cline Christopher R. | officer: CHIEF FINANCIAL OFFICER | M-Exempt | 20,000 | $17.44 | $349K |
| 2026-09-15 | Heerma Peter | officer: EVP, CHIEF COMMERCIAL OFFICER | SELL | 1,431 | $65.31 | $93K |
| 2026-09-17 | Heerma Peter | officer: EVP, CHIEF COMMERCIAL OFFICER | SELL | 8,282 | $65.07 | $539K |
| 2026-09-15 | Inrig Jula | officer: EVP, Head of R&D & CMO | SELL | 25,390 | $62.02 | $1.6M |
| 2026-09-15 | REED ELIZABETH E | officer: Chief Legal Officer and GC | SELL | 1,400 | $63.69 | $89K |
| 2026-09-15 | Heerma Peter | officer: EVP, CHIEF COMMERCIAL OFFICER | SELL | 1,400 | $63.65 | $89K |
| 2026-09-15 | Inrig Jula | officer: EVP, Head of R&D & CMO | SELL | 17,284 | $62.62 | $1.1M |
| 2026-09-15 | REED ELIZABETH E | officer: Chief Legal Officer and GC | SELL | 13,874 | $62.63 | $869K |
| 2026-09-15 | Heerma Peter | officer: EVP, CHIEF COMMERCIAL OFFICER | M-Exempt | 36,526 | $8.93 | $326K |
| 2026-09-15 | Heerma Peter | officer: EVP, CHIEF COMMERCIAL OFFICER | M-Exempt | 1,381 | $22.40 | $31K |
| 2026-09-16 | Heerma Peter | officer: EVP, CHIEF COMMERCIAL OFFICER | M-Exempt | 17,717 | $26.88 | $476K |
| 2026-09-16 | Heerma Peter | officer: EVP, CHIEF COMMERCIAL OFFICER | SELL | 79,113 | $63.65 | $5.0M |
| 2026-09-15 | Calvin Sandra | officer: SVP, CHIEF ACCOUNTING OFFICER | SELL | 4,275 | $62.13 | $266K |
| 2026-09-15 | Inrig Jula | officer: EVP, Head of R&D & CMO | M-Exempt | 32,395 | $8.93 | $289K |
| 2026-09-15 | Cline Christopher R. | officer: CHIEF FINANCIAL OFFICER | SELL | 27,473 | $62.00 | $1.7M |
| 2026-09-15 | Cline Christopher R. | officer: CHIEF FINANCIAL OFFICER | SELL | 20,735 | $62.61 | $1.3M |